Then, in 2022, a higher 2 mg dose gained approval, with clinical trials showing up to 73 percent of type 2 diabetic users achieving the recommended blood sugar levels of less than 7 percent, as recommended by the American Diabetes Association
And weight-loss results from drugs alone are very similar to those of the National Diabetes Prevention Program (the most researched lifestyle change program in the United States) which averages 7% weight-loss over 12-months
Peptide Vials (24 mg vials) 24 mg vial is a common large-format option
Noom GLP-1 Rx Plus Program GLP-1 treatment paired with Noom behavior change Program 2 Includes medication (if prescribed), ongoing care, and full program access
ClinicalTrials.gov records show ongoing or recently updated trial activity, reinforcing that the compound remains under investigation
The underlying fat loss is often sustained as long as weight loss is maintained